CBDL (CBD Life Sciences) Total Equity: $0.21 Mil (As of Sep. 2015)


What is CBD Life Sciences Total Equity?

CBD Life Sciences CBDL -15.00% Total Equity is $0.21 Mil as of Sep. 2015.

CBD Life Sciences's total equity for the quarter that ended in Sep. 2015 was $0.21 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

CBD Life Sciences Total Equity Historical Data

* Premium members only.

The historical data trend for CBD Life Sciences's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CBD Life Sciences Total Equity Chart

CBD Life Sciences Annual Data
Trend Dec11 Dec12 Dec13 Dec14
Total Equity
0.48 0.40 0.08 -0.01

CBD Life Sciences Quarterly Data
Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.17 -0.01 0.26 0.23 0.21

CBD Life Sciences Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

CBD Life Sciences's Total Equity for the fiscal year that ended in Dec. 2014 is calculated as

Total Equity=Total Assets(Q: Dec. 2014 )-Total Liabilities(Q: Dec. 2014 )
=0.632-0.645
=-0.01

CBD Life Sciences's Total Equity for the quarter that ended in Sep. 2015 is calculated as

Total Equity=Total Assets(Q: Sep. 2015 )-Total Liabilities(Q: Sep. 2015 )
=0.621-0.412
=0.21

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of $0.21 Mil mean?
CBD Life Sciences (CBDL) has a Total Equity of $0.21 Mil as of Sep. 2015. The total amount of equity as record on a company's balance sheet. View historical data for CBD Life Sciences and its competitors.
Is CBD Life Sciences' Total Equity too high?
CBD Life Sciences' current Total Equity is $0.21 Mil.
How does CBD Life Sciences' Total Equity compare to QPAG and ADGO?
CBD Life Sciences' Total Equity of $0.21 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Drug Manufacturers company?
A good Total Equity depends on the Drug Manufacturers industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for CBD Life Sciences and its competitors. CBD Life Sciences's current Total Equity is $0.21 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CBD Life Sciences stock overvalued right now?
CBD Life Sciences (CBDL) has a current Total Equity of $0.21 Mil. The current Total Equity is $0.21 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For CBD Life Sciences (CBDL), the current Total Equity is $0.21 Mil as of Sep. 2015. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

CBD Life Sciences Business Description

Address 10953 N. Frank Llyod Wright Boulevard, Unit 108, Scottsdale, AZ, USA, 85259
CBD Life Sciences Inc is developing and marketing a line of cannabidiol-based organic products such as hemp drops, massage oils, recovery pain relief creams, anxiety and sleep solutions supplements, edibles, and a full line of pet products.